Skip to main content
Equibles
CHRS logo

CHRS · Coherus Oncology, Inc. · Short Interest

Track CHRS — free

Use CHRS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.34 -0.03 (-2.19%)
Russell 2000 member Rebalance outlook locked
Market Cap
$213.98M
Shares
154.50M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

CHRS Latest Reported Short Interest

FINRA reported 23,997,214 CHRS shares sold short as of the August 14, 2026 settlement date, a decrease of 529,838 shares. Days to cover was 19.71 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

CHRS Short Interest Forecast

Equibles' model estimates 22,952,958 shares sold short for the August 31, 2026 settlement, -4.4% versus the latest reported position, with a likely range of 21,055,555 to 24,697,035 shares. This model prediction uses FINRA data through August 31, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 31 High confidence 72% chance it falls
22,952,958 -4.4% vs reported
Likely range 21,055,555 to 24,697,035 The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
68/100
Short interest 15.5% of shares — P96 Days to cover 19.7 — P96 Price vs VWAP -2.3% — P45 Short-volume trend -4.8% — P33 Short interest change -2.2% — P44 Worst FTD 0.00% of shares — P37

Positioning score 67.7 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-08-14). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-09-09 15:34 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-09-15 Scheduled
    FINRA publishes Sep 24
    		 — — — —
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 23,997,214 24,527,052 -529,838 19.71
    2026-07-31 24,527,052 23,885,705 +641,347 53.59
    2026-07-15 23,885,705 25,975,163 -2,089,458 24.36
    2026-06-30 25,975,163 25,637,521 +337,642 21.88
    2026-06-15 25,637,521 27,872,603 -2,235,082 33.41
    2026-05-29 27,872,603 28,108,039 -235,436 23.66
    2026-05-15 28,108,039 27,818,409 +289,630 17.16
    2026-04-30 27,818,409 27,972,356 -153,947 25.51
    2026-04-15 27,972,356 28,142,006 -169,650 34.70
    2026-03-31 28,142,006 28,025,097 +116,909 20.68
    2026-03-13 28,025,097 27,657,585 +367,512 17.49
    2026-02-27 27,657,585 29,614,243 -1,956,658 20.59
    2026-02-13 29,614,243 29,597,546 +16,697 12.22
    2026-01-30 29,597,546 29,738,849 -141,303 5.77
    2026-01-15 29,738,849 29,066,312 +672,537 18.03
    2025-12-31 29,066,312 29,855,093 -788,781 38.11
    2025-12-15 29,855,093 29,639,306 +215,787 29.33
    2025-11-28 29,639,306 29,176,605 +462,701 28.21
    2025-11-14 29,176,605 30,098,437 -921,832 16.77
    2025-10-31 30,098,437 30,165,888 -67,451 33.32
    2025-10-15 30,165,888 31,138,131 -972,243 28.00
    2025-09-30 31,138,131 31,866,663 -728,532 19.93
    2025-09-15 31,866,663 31,928,030 -61,367 27.18

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1512762 CUSIP 19249H103 13F (30d) 96 filings 96 filers Visit website Investor relations